{"nct_id":"NCT00086593","title":"Study Of An FDA-approved Drug As Additional Therapy In Patients With Schizophrenia","status":"COMPLETED","status_verified_date":"2016-10","start_date":"2004-05","start_date_type":null,"primary_completion_date":"2005-07","primary_completion_date_type":"ACTUAL","completion_date":"2005-07","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GSK"]}